Skip to main content

Tomàs Pumarola Suñé

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Tomàs Pumarola Suñé

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Projects

Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Maria Belén Viñado Perez, Gema Codina Grau, Virginia Rodríguez Garrido, Andres Antón Pagarolas, Juliana Esperalba Esquerra, Ariadna Rando Segura, Alba Mir Cros, Yannick Hoyos Mallecot, Joan Joseph Munné, Tomàs Pumarola Suñé, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Albert Moreno Mingorance, Maria Piñana Moro, Aroa Silgado Gimenez, Elena Sulleiro Igual, Lidia Goterris Bonet, Josep Roca Grande, Alejandra Gonzalez Sánchez, Narcís Saubí Roca, Jesus Trejo Zahinos
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01129
Duration: 01/01/2022 - 30/06/2025

Sistema integral para la vigilancia clínica, epidemiológica y microbiológica (SiVEV/BCN) de la enfermedad asociada a enterovirus en Barcelona ciudad.

IP: Andres Antón Pagarolas
Collaborators: Juliana Esperalba Esquerra, Jorgina Vila Soler, Yolima Cossio Gil, Rocío Rodrigo García, Tomàs Pumarola Suñé, Maria Espiau Guarner, Núria Worner Tomasa, Maria Piñana Moro, Ariadna Carsi Durall, Anna Creus Costa, Alejandra Gonzalez Sánchez, Cristina Andrés Vergés, Narcís Saubí Roca
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI22/00023
Duration: 01/01/2023 - 31/12/2025

CIBER Malalties Infeccioses

IP: Juan Jose Gonzalez Lopez
Collaborators: Benito Almirante Gragera, María Nieves Larrosa Escartin, Oscar Len Abad, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Javier Gomis Rodriguez, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, CIBER Malalties Infeccioses, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 100500
Reference: CB21/13/00054
Duration: 01/01/2022 - 31/12/2022

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: COVID-19, PERFIL INMUNOLÓGICO DE RIESGO
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Ana María García Arumí

Ana María García Arumí

Biomedical Research in Cancer Stem Cells
Read more
Bonilla Pellegrini, Sergio Rene

Bonilla Pellegrini, Sergio Rene

Predoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Victor Monforte Torres

Victor Monforte Torres

Main researcher
Pneumology
Read more
Segura Dávila, Karen

Segura Dávila, Karen

Administration and Management
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.